New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.50-0.19 (-2.84%)
At close: 04:00PM EST
6.47 -0.03 (-0.46%)
After hours: 06:27PM EST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-47,461
-42,347
-45,640
-111,269
-71,454
Depreciation & amortisation
1,402
1,488
1,639
1,694
1,230
Stock-based compensation
3,940
5,720
9,480
12,458
11,982
Change in working capital
4,534
-4,024
-15,696
-3,205
12,476
Accounts receivable
-
-
-
0
5,000
Accounts payable
3,508
-256.835
-5,956
-3,469
4,366
Other working capital
-37,547
-37,558
-48,238
-100,170
-48,463
Other non-cash items
836.622
742.478
950.613
291.392
-
Net cash provided by operating activities
-37,547
-37,544
-48,184
-99,686
-45,721
Cash flows from investing activities
Investments in property, plant and equipment
-
-13.449
-54.172
-484.491
-2,743
Purchases of investments
-28,160
-86,342
-87,267
-
-
Sales/maturities of investments
65,193
116,421
13,880
-
-
Net cash used for investing activities
37,033
30,074
-73,417
-484.491
-2,743
Cash flows from financing activities
Debt repayment
-2,643
-2,368
-926.595
-951.876
-605.535
Common stock issued
244.105
0
62,586
142,201
40,677
Other financing activities
-
-
-1,820
-6,039
-2,572
Net cash used provided by (used for) financing activities
-681.502
-533.615
60,823
154,875
38,463
Net change in cash
-1,195
-8,004
-60,777
54,705
-10,000
Cash at beginning of period
13,114
25,677
86,453
31,749
41,748
Cash at end of period
11,919
17,673
25,677
86,453
31,749
Free cash flow
Operating cash flow
-37,547
-37,544
-48,184
-99,686
-45,721
Capital expenditure
-
-13.449
-54.172
-484.491
-2,743
Free cash flow
-37,547
-37,558
-48,238
-100,170
-48,463